Location History:
- Louisville, TN (US) (2017)
- Knoxville, TX (US) (2018)
Company Filing History:
Years Active: 2017-2018
Title: Mark Haig Khachaturian: Innovator in Radiopharmaceutical Production
Introduction
Mark Haig Khachaturian is a notable inventor based in Knoxville, TX (US). He has made significant contributions to the field of radiopharmaceuticals, holding 2 patents that enhance the efficiency and effectiveness of biomarker production systems.
Latest Patents
Khachaturian's latest patents include a "Dose synthesis card for use with automated biomarker production system" and a "Microfluidic radiopharmaceutical production system and process." The first patent focuses on synthesizing approximately ten unit doses of radiopharmaceutical biomarkers for use in positron emission tomography (PET). This innovative process involves introducing a radioisotope into a reaction vessel with organic and aqueous reagents, which are then heated to create a solution of the desired radiopharmaceutical. The solution undergoes purification through a combination of solid phase extraction components, trap and release components, and a filter. This synthesis process minimizes waste and allows for on-site production of radiopharmaceuticals, reducing the time between synthesis and administration to patients.
The second patent, "Radioisotope target assembly," describes a target assembly designed to produce radioisotopes for synthesizing radiopharmaceuticals. This assembly includes a target vessel with a chamber that receives target material, covered by a thin, particle-permeable sheet. During the bombardment process, a high-energy particle beam strikes the cover sheet, allowing particles to penetrate the target chamber and interact with the target material, thus altering its nuclear makeup to produce radioisotopes.
Career Highlights
Khachaturian is currently employed at Abt Molecular Imaging, Inc., where he continues to innovate in the field of radiopharmaceuticals. His work is pivotal in advancing the production processes that are crucial for medical applications.
Collaborations
He collaborates with esteemed colleagues such as Ronald Nutt and David Patton, Sr., contributing to a dynamic team focused on enhancing radiopharmaceutical technologies.
Conclusion
Mark Haig Khachaturian's contributions to the field of radiopharmaceuticals through his innovative patents and collaborative efforts mark him as a significant figure in medical technology. His work not only improves production efficiency but also enhances patient care by ensuring timely administration of critical radiopharmaceuticals.